
Sign up to save your podcasts
Or


At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.

91,010 Listeners

21,960 Listeners

43,598 Listeners

91 Listeners

6,400 Listeners

112,416 Listeners

4 Listeners

56,511 Listeners

0 Listeners

10,223 Listeners

33 Listeners

3,013 Listeners

8,200 Listeners

29,248 Listeners

1,562 Listeners

4,222 Listeners

7 Listeners

578 Listeners

10,609 Listeners